Literature DB >> 6156332

Use of first-dose response or plasma renin activity to predict the long-term effect of captopril: identification of triphasic pattern of blood pressure response.

D B Case, S A Atlas, J H Laragh, P A Sullivan, J E Sealey.   

Abstract

A triphasic pattern of blood pressure response was observed in 13 of 26 patients treated with captopril. Pressure fell after the first dose in all but 3 patients, reaching a minimum by 90 min. Over the next several days, pressure either remained at this level (n = 13) or returned towards control levels (n = 13) even with increased dosage. Blood pressure then fell gradually, usually reaching a level by 10 days that was equal to or slightly lower than that after the first dose. The secondary rise in blood pressure was more frequent and pronounced in patients who had larger initial responses and higher renin levels. The transient increase in pressure could not be explained by failure of blockade of the renin system, since aldosterone excretion was maximally suppressed by the second day of treatment. The data indicate that both the blood pressure response to the first dose and the renin level can be used to predict the long-term response to captopril.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156332     DOI: 10.1097/00005344-198007000-00001

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

1.  Pharmacological investigations of a new renin inhibitor in normal sodium-unrestricted volunteers.

Authors:  M de Gasparo; F Cumin; J Nussberger; T T Guyenne; J M Wood; J Menard
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

Review 2.  Selecting appropriate antihypertensive drug dosages.

Authors:  G D Johnston
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 3.  Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification.

Authors:  M Packer
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

4.  The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.

Authors:  A A Ajayi; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

5.  Captopril and opiate antagonism in essential hypertension.

Authors:  A A Ajayi; P C Rubin; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

6.  Effects of the single and repeated administration of benazepril on systemic and forearm circulation and cardiac function in hypertensive patients.

Authors:  N De Luca; S Savonitto; B Ricciardelli; R Marchegiano; F Lamenza; G Lembo; B Trimarco
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

7.  Relation of plasma renin activity to the antihypertensive effect of MK 421 in the rat.

Authors:  D Bradshaw; P H Franz; A L Sugden
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

Review 8.  An overview of the clinical pharmacology of enalapril.

Authors:  R O Davies; H J Gomez; J D Irvin; J F Walker
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 9.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

10.  Psychological characteristics and responses to antihypertensive drug therapy.

Authors:  Samuel J Mann; Linda M Gerber
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jan-Feb       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.